Introducing: PayerView
The proprietary U.S. reimbursement simulation engine
See Your Product Through a U.S. Payer’s Eyes.
DTxCC PayerView helps pharmaceutical, digital health, medical device and diagnostics companies understand how U.S. payers are likely to evaluate a product for coverage and reimbursement. It applies patterns derived from actual payer interviews to verified product facts, current market-access evidence, pricing assumptions and the client’s specific commercialization questions.
The result is a focused, directionally accurate assessment of likely payer decision logic, reimbursement pathways, coverage barriers, evidence expectations and pricing concerns—without the time and cost of a six-to-eight-week qualitative research project. Use it to strengthen payer strategy and pressure-test assumptions.
DTxCC Provides Real-World, Hands-On Expertise in Digital Therapeutics & Digital Health Products
_edited.png)
Specializing In
Market Access
Stakeholder Research
Go-to-Market Strategy
DTxCC provides guidance through each stage of business development, maximizing commercialization opportunities in digital therapeutics. Our team of expert consultants brings their deep digital therapeutics experience and supports end-to-end business planning by evaluating and creating a customized plan for your business.
DTxCC Case Studies
Digital Health Commercialization
Digital Health Commercialization. DTxCC Case Study
Go-to-Market Strategy Development. DTxCC Case Study.
.png)
Our Clients
What People Say About DTxCC
I hired DTxCC to conduct a payer Advisory Board project to determine the best opportunity for reimbursement for our digital therapeutic (Freespira). The insights gained from the research and Rick’s analysis and knowledge of the payer environment allowed us to make important decisions about our reimbursement strategy. Since then, I have referred other Digital Therapeutic companies to Rick and he has conducted market opportunity assessments, helped define reimbursement opportunities, detailed business models, conducted payer and HCP market research, and designed go-to-market strategies and Business plans. I highly recommend Rick/DTxCC for any digital therapeutic commercialization needs you may have.
-- Debra Reisenthel, Founding CEO (Freespira, Inc.)
